Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Clinical Trial of rhGM-CSF Hydro-gel for Topical Application on Deep 2nd Partial Thickness Burn

NCT01785784 is registered in ClinicalTrials.gov with Changchun GeneScience Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01785784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01785784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Clinical Trial of rhGM-CSF Hydro-gel for Topical Application on Deep 2nd Partial Thickness Burn
Lead sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
July 31, 2012
Enrollment
2,510 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

deep partial thickness burn